JP2016121171A5 - - Google Patents

Download PDF

Info

Publication number
JP2016121171A5
JP2016121171A5 JP2016015912A JP2016015912A JP2016121171A5 JP 2016121171 A5 JP2016121171 A5 JP 2016121171A5 JP 2016015912 A JP2016015912 A JP 2016015912A JP 2016015912 A JP2016015912 A JP 2016015912A JP 2016121171 A5 JP2016121171 A5 JP 2016121171A5
Authority
JP
Japan
Prior art keywords
group
alkyl
infection
pharmaceutically acceptable
nitrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016015912A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016121171A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016121171A publication Critical patent/JP2016121171A/ja
Publication of JP2016121171A5 publication Critical patent/JP2016121171A5/ja
Pending legal-status Critical Current

Links

JP2016015912A 2009-10-16 2016-01-29 抗微生物性化合物および抗微生物性化合物の製造方法および使用方法 Pending JP2016121171A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US25247809P 2009-10-16 2009-10-16
US61/252,478 2009-10-16
US31428710P 2010-03-16 2010-03-16
US61/314,287 2010-03-16
US35820110P 2010-06-24 2010-06-24
US61/358,201 2010-06-24

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012534413A Division JP2013508299A (ja) 2009-10-16 2010-10-15 抗微生物性化合物および抗微生物性化合物の製造方法および使用方法

Publications (2)

Publication Number Publication Date
JP2016121171A JP2016121171A (ja) 2016-07-07
JP2016121171A5 true JP2016121171A5 (cg-RX-API-DMAC10.html) 2016-08-18

Family

ID=43876906

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2016015912A Pending JP2016121171A (ja) 2009-10-16 2016-01-29 抗微生物性化合物および抗微生物性化合物の製造方法および使用方法
JP2016037911A Withdrawn JP2016153405A (ja) 2009-10-16 2016-02-29 抗微生物性化合物および抗微生物性化合物の製造方法および使用方法
JP2016054375A Withdrawn JP2016172733A (ja) 2009-10-16 2016-03-17 抗微生物性化合物および抗微生物性化合物の製造方法および使用方法
JP2017148530A Pending JP2018024653A (ja) 2009-10-16 2017-07-31 抗微生物性化合物および抗微生物性化合物の製造方法および使用方法
JP2017148521A Pending JP2018039784A (ja) 2009-10-16 2017-07-31 抗微生物性化合物および抗微生物性化合物の製造方法および使用方法
JP2018182217A Pending JP2019038808A (ja) 2009-10-16 2018-09-27 抗微生物性化合物および抗微生物性化合物の製造方法および使用方法

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2016037911A Withdrawn JP2016153405A (ja) 2009-10-16 2016-02-29 抗微生物性化合物および抗微生物性化合物の製造方法および使用方法
JP2016054375A Withdrawn JP2016172733A (ja) 2009-10-16 2016-03-17 抗微生物性化合物および抗微生物性化合物の製造方法および使用方法
JP2017148530A Pending JP2018024653A (ja) 2009-10-16 2017-07-31 抗微生物性化合物および抗微生物性化合物の製造方法および使用方法
JP2017148521A Pending JP2018039784A (ja) 2009-10-16 2017-07-31 抗微生物性化合物および抗微生物性化合物の製造方法および使用方法
JP2018182217A Pending JP2019038808A (ja) 2009-10-16 2018-09-27 抗微生物性化合物および抗微生物性化合物の製造方法および使用方法

Country Status (10)

Country Link
JP (6) JP2016121171A (cg-RX-API-DMAC10.html)
KR (3) KR101857694B1 (cg-RX-API-DMAC10.html)
CN (5) CN104628729B (cg-RX-API-DMAC10.html)
AR (3) AR080617A1 (cg-RX-API-DMAC10.html)
EA (1) EA201500913A1 (cg-RX-API-DMAC10.html)
MY (2) MY165011A (cg-RX-API-DMAC10.html)
NZ (2) NZ623384A (cg-RX-API-DMAC10.html)
PH (1) PH12012500732A1 (cg-RX-API-DMAC10.html)
SG (3) SG10201406635QA (cg-RX-API-DMAC10.html)
TW (8) TW201726630A (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6274723B2 (ja) 2009-10-16 2018-02-07 メリンタ セラピューティクス,インコーポレイテッド 抗微生物性化合物および抗微生物性化合物の製造方法および使用方法
NZ623384A (en) * 2009-10-16 2016-06-24 Melinta Therapeutics Inc Antimicrobial compounds and methods of making and using the same
JP2013508299A (ja) 2009-10-16 2013-03-07 リブ−エックス ファーマシューティカルズ,インコーポレイテッド 抗微生物性化合物および抗微生物性化合物の製造方法および使用方法
EP3404028A1 (en) * 2011-04-15 2018-11-21 Melinta Therapeutics, Inc. Methods of making antimicrobial compounds
US9937183B2 (en) 2013-09-09 2018-04-10 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
MX2016002975A (es) 2013-09-09 2016-10-21 Melinta Therapeutics Inc Compuestos antimicrobianos y métodos de fabricación y utilización de los mismos.
WO2016145417A1 (en) 2015-03-11 2016-09-15 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
US11098047B2 (en) 2016-05-06 2021-08-24 BioVersys AG Antimicrobials and methods of making and using same

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980781A (en) * 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
US3673184A (en) * 1970-09-02 1972-06-27 Dainippon Pharmaceutical Co Certain 2-substituted-5,8-dihydro-5-oxopyrido{8 2,3-d{9 pyrimidine-6-carboxylic acid derivatives
EP0067610A1 (en) * 1981-06-16 1982-12-22 Beecham Group Plc Penicillins, a process for their preparation and compositions containing them
ZA835684B (en) * 1982-08-27 1985-03-27 Roussel Uclaf Imidazo(1,2-a)pyrimidines
IT1197876B (it) * 1986-10-15 1988-12-21 Pharmachim Engineering Srl Procedimento per la preparazione dell'acido 5,8-diidro-8-etil-5-osso-2-(1-piperazinil)pirido(2,3-d)pirimidin-6-carbossilico
JP2549931B2 (ja) * 1990-01-12 1996-10-30 株式会社大塚製薬工場 ピリミドベンズイミダゾール誘導体
JP2991382B2 (ja) * 1990-07-18 1999-12-20 大日本製薬株式会社 縮合三環式化合物およびその塩
JP2811230B2 (ja) * 1990-10-17 1998-10-15 コニカ株式会社 新規な写真用カプラー
US5208141A (en) * 1990-10-09 1993-05-04 Konica Corporation Silver halide color photographic light-sensitive material
US6451968B1 (en) * 1991-05-24 2002-09-17 Isis Pharmaceuticals, Inc. Peptide nucleic acids
US5434257A (en) * 1992-06-01 1995-07-18 Gilead Sciences, Inc. Binding compentent oligomers containing unsaturated 3',5' and 2',5' linkages
US5646163A (en) * 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
IT1263804B (it) * 1993-01-22 1996-09-03 Luso Farmaco Inst Derivati pirimidinonici fusi con eterocicli azotati ad attivita' a ii antagonista
RU2139862C1 (ru) * 1993-05-12 1999-10-20 Е.И. Дю Пон де Немурс энд Компани Замещенные 4(3н)-хиназолиноны, обладающие фунгицидными свойствами, композиции на их основе и способы борьбы с мучнистой росой
US5502177A (en) * 1993-09-17 1996-03-26 Gilead Sciences, Inc. Pyrimidine derivatives for labeled binding partners
US5668127A (en) * 1995-06-26 1997-09-16 Pathogenesis Corporation Nitroimidazole antibacterial compounds and methods of use thereof
AU1292899A (en) * 1997-11-07 1999-05-31 Isis Pharmaceuticals, Inc. Pyrimidine derivatives for labeled binding partners
DE19838998A1 (de) * 1998-08-27 2000-03-09 Bayer Ag Neue Naturstoffderivate
SE9903894D0 (sv) * 1999-10-28 1999-10-28 New Pharma Research Ab Novel compounds
KR20090089922A (ko) * 2000-10-18 2009-08-24 파마셋 인코포레이티드 바이러스 감염 및 비정상적인 세포 증식의 치료를 위한 변형된 뉴클레오시드
DE10061538A1 (de) * 2000-12-11 2002-06-20 Bayer Ag Ureido-Dihydropyrimidinone
DE10061542A1 (de) * 2000-12-11 2002-06-13 Bayer Ag Alkanoylamino-pyrimidine
ATE304539T1 (de) * 2000-12-14 2005-09-15 Procter & Gamble Antimikrobielle chinolone
WO2002061110A2 (en) * 2001-01-29 2002-08-08 Bio-Rad Laboratories, Inc. Nucleic acid derivatives
TWI248936B (en) * 2001-03-21 2006-02-11 Merck Sharp & Dohme Imidazo-pyrimidine derivatives as ligands for GABA receptors
US20030207804A1 (en) * 2001-05-25 2003-11-06 Muthiah Manoharan Modified peptide nucleic acids
JP2005504020A (ja) * 2001-07-03 2005-02-10 アイシス・ファーマシューティカルス・インコーポレーテッド ヌクレアーゼ耐性キメラオリゴヌクレオチド
JP4306206B2 (ja) * 2001-09-04 2009-07-29 住友化学株式会社 イミダゾ[1,2−a]ピリミジン、その用途およびその製造中間体
GB0205165D0 (en) * 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
WO2004080466A1 (en) * 2003-03-07 2004-09-23 Ribapharm Inc. Cytidine analogs and methods of use
KR20060069836A (ko) * 2003-08-12 2006-06-22 아칠리온 파르마세우티칼스 인코포레이티드 항-감염제로서의 이소티아졸로퀴놀론 및 관련 화합물
ES2352799T3 (es) * 2005-07-27 2011-02-23 Achillion Pharmaceuticals, Inc. 8-metoxi-9h-isotiazolo[5,4-b]quinolina-3,4-dionas y compuestos relacionados.
WO2007101871A1 (de) * 2006-03-08 2007-09-13 Basf Se Substituierte imidazolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel
WO2008082440A2 (en) * 2006-08-25 2008-07-10 Emory University Fluorescent nucleoside analogues
EP1964841A1 (en) * 2007-02-28 2008-09-03 sanofi-aventis Imidazo[1,2-a]azine and their use as pharmaceuticals
KR20090098710A (ko) * 2008-03-14 2009-09-17 주식회사 씨티아이바이오 세포투과성과 핵산 결합력이 좋은 펩타이드 핵산 유도체
NZ623384A (en) * 2009-10-16 2016-06-24 Melinta Therapeutics Inc Antimicrobial compounds and methods of making and using the same

Similar Documents

Publication Publication Date Title
JP2013508297A5 (cg-RX-API-DMAC10.html)
JP2013508299A5 (cg-RX-API-DMAC10.html)
JP2013508298A5 (cg-RX-API-DMAC10.html)
RU2399620C2 (ru) Производные хинуклидина и их применение в качестве антагонистов мускариновых рецепторов м3
JP2014510788A5 (cg-RX-API-DMAC10.html)
US10857138B2 (en) Pharmaceutical compositions comprising antibacterial agents
Chiu et al. Development of novel antibacterial agents against methicillin-resistant Staphylococcus aureus
CN108570032A (zh) 新型罗丹明染料及其在抗致病菌中的应用
CN109310682A (zh) 抗菌组合物
JP2018507257A5 (cg-RX-API-DMAC10.html)
EP3166955A1 (en) Hamamelitannin analogues and uses thereof
JP2022166191A (ja) 新規の抗マイコバクテリア複素環式アミド
CN105792827B (zh) 抗菌组合物
CN106029068A (zh) 包含抗菌剂的药物组合
EP3116545A1 (en) Pharmaceutical compositions comprising antibacterial agents
TWI881977B (zh) 用於消除耳念珠菌移生之抗真菌劑
JP2015531375A (ja) 三環系テトラヒドロキノリン抗菌剤
JP2006508178A (ja) 抗菌性ピラゾールカルボン酸ヒドラジド
JP2017511359A (ja) 抗菌薬を含む医薬組成物
JP6626516B2 (ja) 抗菌組成物及び方法
CN106102741A (zh) 包含抗菌剂的药物组合物
CN106163519A (zh) 包含抗菌剂的药物组合物
WO2020208093A1 (en) Cysteine derivatives for treatment and prevention of bacterial infections
WO2015063714A1 (en) Pharmaceutical compositions comprising antibacterial agents
JP2002161041A (ja) 感染症治療剤